A toxic chemical long considered hostile to life on Mars, may not be an obstacle to building on the Red Planet after all. Instead, it could.
Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...
Ridley Scott's inimitable 1979 sci-fi thriller, Alien, expertly ratchets up the tension by not having the titular alien show up on screen until roughly an hour into the film. Following in Scott's ...
In July, researchers using the NASA-funded Asteroid Terrestrial-impact Last Alert System survey telescope in Chile made an exceedingly rare discovery: a mysterious object passing through the solar ...
A Texas teenager was rescued by her father after she was forced into a truck at knifepoint on Christmas Day, police said. Patrol deputies with the Montgomery County Sheriff's Office were called to an ...
Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...
Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial. The single-site study randomized 60 people with early to ...
At its annual Ecosystem Day on December 12, Hithium Energy Storage signaled a strategic improvement beyond conventional four-hour batteries, positioning long-duration storage as both a grid asset and ...
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Please provide your email address to receive an email when new articles are posted on . Using data from the 2023-2024 influenza season, researchers determined cell-based influenza vaccines were ...